Evidence map›Paper›PMID 37935717›Full record

ArticleSchizophrenia (Heidelberg, Germany)2023

Influence of psychopathology and metabolic parameters on quality of life in patients with first-episode psychosis before and after initial antipsychotic treatment.

Anne Sofie A Dahl, Victor Sørensen, Karen S Ambrosen, Mikkel E Sørensen, Grímur H Mohr, Mette Ø Nielsen, Kirsten B Bojesen, Birte Y Glenthøj, Margaret Hahn, Julie Midtgaard and 1 more

Abstract read
In one paragraph

Article in Schizophrenia (Heidelberg, Germany), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Anne Sofie A DahlCenter for Clinical Intervention and Neuropsychiatric Schizophrenia Research (CINS) & Center for Neuropsychiatric Schizophrenia Research (CNSR), Copenhagen University Hospital-Mental Health Services Copenhagen, Copenhagen, Denmark.
Victor SørensenCentre for Applied Research in Mental Health Care (CARMEN), Copenhagen University Hospital-Mental Health Services Copenhagen, Copenhagen, Denmark.ORCID http://orcid.org/0000-0002-0253-7544
Karen S AmbrosenCenter for Clinical Intervention and Neuropsychiatric Schizophrenia Research (CINS) & Center for Neuropsychiatric Schizophrenia Research (CNSR), Copenhagen University Hospital-Mental Health Services Copenhagen, Copenhagen, Denmark.ORCID http://orcid.org/0000-0002-5638-2357
Mikkel E SørensenCenter for Clinical Intervention and Neuropsychiatric Schizophrenia Research (CINS) & Center for Neuropsychiatric Schizophrenia Research (CNSR), Copenhagen University Hospital-Mental Health Services Copenhagen, Copenhagen, Denmark.
Grímur H MohrCenter for Clinical Intervention and Neuropsychiatric Schizophrenia Research (CINS) & Center for Neuropsychiatric Schizophrenia Research (CNSR), Copenhagen University Hospital-Mental Health Services Copenhagen, Copenhagen, Denmark.
Mette Ø NielsenCenter for Clinical Intervention and Neuropsychiatric Schizophrenia Research (CINS) & Center for Neuropsychiatric Schizophrenia Research (CNSR), Copenhagen University Hospital-Mental Health Services Copenhagen, Copenhagen, Denmark.
Kirsten B BojesenCenter for Clinical Intervention and Neuropsychiatric Schizophrenia Research (CINS) & Center for Neuropsychiatric Schizophrenia Research (CNSR), Copenhagen University Hospital-Mental Health Services Copenhagen, Copenhagen, Denmark.ORCID http://orcid.org/0000-0002-7996-3154
Birte Y GlenthøjCenter for Clinical Intervention and Neuropsychiatric Schizophrenia Research (CINS) & Center for Neuropsychiatric Schizophrenia Research (CNSR), Copenhagen University Hospital-Mental Health Services Copenhagen, Copenhagen, Denmark.ORCID http://orcid.org/0000-0003-3056-7262
Margaret HahnSchizophrenia Division, Centre for Addiction and Mental Health (CAMH), Toronto, ON, Canada.ORCID http://orcid.org/0000-0001-8884-9946
Julie MidtgaardCentre for Applied Research in Mental Health Care (CARMEN), Copenhagen University Hospital-Mental Health Services Copenhagen, Copenhagen, Denmark.ORCID http://orcid.org/0000-0003-2381-2127
Bjørn H EbdrupCenter for Clinical Intervention and Neuropsychiatric Schizophrenia Research (CINS) & Center for Neuropsychiatric Schizophrenia Research (CNSR), Copenhagen University Hospital-Mental Health Services Copenhagen, Copenhagen, Denmark. bjoern.ebdrup@regionh.dk.

Funding

Lundbeckfonden (Lundbeck Foundation) R377-2021-340
6 · The paper itself

Abstract

The impact of psychological and physical health on quality of life (QoL) in patients with early psychosis remain relatively unexplored. We evaluated the predictive value of psychopathological and metabolic parameters on QoL in antipsychotic-naïve patients with first-episode psychosis before and after initial antipsychotic treatment. At baseline, 125 patients underwent assessments of psychopathology, prevalence of metabolic syndrome (MetS), and QoL. After 6 weeks of antipsychotic monotherapy, 89 patients were re-investigated. At baseline, the prevalence of MetS was 19.3% (n = 22). After 6 weeks, body weight (1.3 kg, p < 0.001) and body mass index (0.4 kg/m

Identifiers

PMID37935717
PMCPMC10630335

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.